Get the Stockscreener App
1.445
3.02%
-0.045
After Hours:
1.47
0.025
+1.73%
Fortress Biotech Inc stock is traded at $1.445, with a volume of 573.01K.
It is down -3.02% in the last 24 hours and down -28.82% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
See More
Previous Close:
$1.49
Open:
$1.48
24h Volume:
573.01K
Relative Volume:
1.39
Market Cap:
$33.08M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.0973
EPS:
-14.85
Net Cash Flow:
$-129.56M
1W Performance:
+1.05%
1M Performance:
-28.82%
6M Performance:
-27.75%
1Y Performance:
+397.76%
1-Day Range:
$1.44
$1.48
1-Week Range:
$1.355
$1.54
52-Week Range:
$0.281
$4.64
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Fortress Biotech Inc (FBIO) receives a Buy rating from ROTH MKM - Knox Daily
Fortress Biotech Inc (FBIO)’s results reveal risk - US Post News
Fortress Biotech Inc (FBIO)’s Market Momentum: Closing Strong at 1.49, Up 2.76 - The Dwinnex
(FBIOP) Investment Analysis and Advice - Stock Traders Daily
Fortress Biotech Inc [FBIO] Shares Rise 1.44 % on Wednesday - Knox Daily
FBIOFortress Biotech, Inc. Latest Stock News & Market Updates - StockTitan
Fortress Biotech to Participate in October 2024 Investor Conferences - The Manila Times
Fortress Biotech to Participate in October 2024 Investor Conferences - StockTitan
Fortress Biotech to Participate in October 2024 Investor Conferences - GlobeNewswire
Insider Buying at Fortress Biotech Inc (FBIO): President, CEO & - GuruFocus.com
Fortress Biotech CEO acquires $1.4m in company stock By Investing.com - Investing.com Australia
Fortress Biotech CEO acquires $1.4m in company stock - Investing.com
Fortress Biotech CEO acquires $1.4m in company stock By Investing.com - Investing.com UK
This trade activity should not be overlooked: Fortress Biotech Inc (FBIO) - SETE News
Fortress Biotech Inc (FBIO) shows promising results - US Post News
Investing in Fortress Biotech Inc (FBIO) Is Getting More Attractive - Knox Daily
Ratios Revealed: Decoding Fortress Biotech Inc (FBIO)’s Financial Health - The Dwinnex
Fortress Biotech secures $8 million in stock sales - Investing.com
Fortress Biotech Inc Inc. (FBIO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
A look at FBIO’s current quarter earnings estimates - US Post News
Fortress Biotech secures $8 million in stock sales - Investing.com India
Why Fortress Biotech (FBIO) Stock Is Getting Hammered - Benzinga
Fortress Biotech to sell 3.9M shares at $1.65 in registered direct offering - MSN
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh - StreetInsider.com
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements - GlobeNewswire
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements - StockTitan
Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Bought by Mutual of America Capital Management LLC - Defense World
How To Trade (FBIOP) - Stock Traders Daily
Checkpoint Therapeutics Announces Cosibelimab Longer-Term - GlobeNewswire
Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 - StockTitan
Mustang Bio faces Nasdaq delisting over equity shortfall - Investing.com India
Journey Medical Corporation to Participate in the Lake - GlobeNewswire
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - StockTitan
Fortress Biotech Pref A stock hits 52-week low at $6.06 - Investing.com Canada
Fortress Biotech Inc [FBIO] President, CEO & Chairman makes an insider purchase of 5,000 shares worth 37418.0. - Knox Daily
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Does Fortress Biotech Inc (FBIO) offer a good opportunity for investors? - SETE News
Fortress Biotech (FBIO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
Fortress Biotech, India Fund, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency
Long Term Trading Analysis for (FBIOP) - Stock Traders Daily
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - MSN
Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 20, 2024) - GuruFocus.com
Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 19, 2024) - GuruFocus.com
Fortress Biotech (FRA:CNB1) 14-Day RSI : 43.84 (As of Aug. 19, 2024) - GuruFocus.com
Fortress Biotech (FRA:CNB1) Volatility : 47.06% (As of Aug. 19, 2024) - GuruFocus.com
Fortress Biotech (FRA:CNB0.PFD) EBITDA per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com
Fortress Biotech (FRA:CNB1) GF Value Rank : 2 (As of Aug. 18, 2024) - GuruFocus.com
Fortress Biotech, B. Riley Financial, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):